ZA996758B - Process for the preparation of mometasone furoate. - Google Patents

Process for the preparation of mometasone furoate.

Info

Publication number
ZA996758B
ZA996758B ZA9906758A ZA996758A ZA996758B ZA 996758 B ZA996758 B ZA 996758B ZA 9906758 A ZA9906758 A ZA 9906758A ZA 996758 A ZA996758 A ZA 996758A ZA 996758 B ZA996758 B ZA 996758B
Authority
ZA
South Africa
Prior art keywords
preparation
mometasone furoate
mometasone
furoate
free
Prior art date
Application number
ZA9906758A
Other languages
English (en)
Inventor
William Heggie
Joao Bandarra
Original Assignee
Hovione Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hovione Int Ltd filed Critical Hovione Int Ltd
Publication of ZA996758B publication Critical patent/ZA996758B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA9906758A 1999-08-02 1999-10-27 Process for the preparation of mometasone furoate. ZA996758B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PT102343A PT102343B (pt) 1999-08-02 1999-08-02 Processo para a preparacao de furoato mometasona

Publications (1)

Publication Number Publication Date
ZA996758B true ZA996758B (en) 2000-08-30

Family

ID=20085881

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9906758A ZA996758B (en) 1999-08-02 1999-10-27 Process for the preparation of mometasone furoate.

Country Status (22)

Country Link
US (1) US6177560B1 (zh)
EP (1) EP1074558B1 (zh)
JP (1) JP3746174B2 (zh)
KR (1) KR100640066B1 (zh)
CN (1) CN1149222C (zh)
AT (1) ATE229970T1 (zh)
AU (1) AU765592B2 (zh)
CA (1) CA2295455C (zh)
DE (1) DE69904585T2 (zh)
DK (1) DK1074558T3 (zh)
ES (1) ES2189354T3 (zh)
HR (1) HRP990341B1 (zh)
HU (1) HU227494B1 (zh)
IL (1) IL133752A (zh)
NO (1) NO321154B1 (zh)
NZ (1) NZ500555A (zh)
PL (1) PL191103B1 (zh)
PT (1) PT102343B (zh)
RU (1) RU2208616C2 (zh)
SI (1) SI1074558T1 (zh)
UA (1) UA60333C2 (zh)
ZA (1) ZA996758B (zh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070099883A1 (en) * 2005-10-07 2007-05-03 Cheryl Lynn Calis Anhydrous mometasone furoate formulation
EP1790754A1 (de) * 2005-11-24 2007-05-30 Siemens Aktiengesellschaft Schichtsystem mit Gadolinium-Mischkristall-Pyrochlorphase
US8021742B2 (en) * 2006-12-15 2011-09-20 Siemens Energy, Inc. Impact resistant thermal barrier coating system
ES2774391T3 (es) * 2009-05-29 2020-07-20 Pearl Therapeutics Inc Composiciones, métodos y sistemas para la administración respiratoria de dos o más agentes activos
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
PT105139B (pt) * 2010-06-01 2013-01-29 Hovione Farmaciencia S A Método para a monofluorometilação de substratos orgânicos para preparação de compostos orgânicos biologicamente activos
RU2696582C2 (ru) 2013-03-15 2019-08-05 Перл Терапьютикс, Инк. Способы и системы кондиционирования дисперсных кристаллических материалов
MX2015016058A (es) 2013-05-22 2016-12-20 Pearl Therapeutics Inc Composiciones, metodos y sistemas para el suministro por via respiratoria de tres o mas agentes activos.
CN105481933B (zh) * 2015-12-25 2017-09-19 山东京卫制药有限公司 一种合成糠酸莫米松的方法
CN105566437B (zh) * 2015-12-30 2018-07-20 山东京卫制药有限公司 一种8dm衍生物及利用其合成糠酸莫米松的方法
CN107266518B (zh) * 2016-04-08 2021-03-30 天津金耀集团有限公司 一种糠酸莫米松晶型及其制备方法
IL309888A (en) 2021-07-09 2024-03-01 Astrazeneca Pharmaceuticals Lp Aerosol drug delivery compounds, methods and systems
WO2023119093A1 (en) 2021-12-20 2023-06-29 Astrazeneca Ab Compositions, methods and systems for aerosol drug delivery

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3260474D1 (en) * 1981-02-02 1984-09-06 Schering Corp Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them
KR100441187B1 (ko) * 1996-06-28 2004-11-03 쉐링 코포레이션 9α,21-디할로-프레그난-11β,17α-디올-20-온의17-에스테르의제조방법
US5886200A (en) * 1996-07-01 1999-03-23 Schering Corporation Process for the preparation of 17-esters of 9 α, 21-dihalo-pregnane-11 β, 17 α-diol-20-ones

Also Published As

Publication number Publication date
HRP990341B1 (en) 2003-10-31
CN1282744A (zh) 2001-02-07
HUP9903747A2 (hu) 2001-05-28
ATE229970T1 (de) 2003-01-15
CN1149222C (zh) 2004-05-12
HU9903747D0 (en) 1999-12-28
IL133752A (en) 2004-02-19
AU765592B2 (en) 2003-09-25
JP2001048897A (ja) 2001-02-20
PL191103B1 (pl) 2006-03-31
AU5602499A (en) 2001-02-08
NZ500555A (en) 2000-11-24
PT102343B (pt) 2003-11-28
JP3746174B2 (ja) 2006-02-15
ES2189354T3 (es) 2003-07-01
US6177560B1 (en) 2001-01-23
HUP9903747A3 (en) 2001-07-30
KR100640066B1 (ko) 2006-10-31
IL133752A0 (en) 2001-04-30
HU227494B1 (en) 2011-07-28
NO995225L (no) 2001-02-05
EP1074558B1 (en) 2002-12-18
DE69904585T2 (de) 2003-05-15
RU2208616C2 (ru) 2003-07-20
EP1074558A1 (en) 2001-02-07
KR20010020094A (ko) 2001-03-15
UA60333C2 (uk) 2003-10-15
PL336452A1 (en) 2001-02-12
PT102343A (pt) 2001-02-28
DE69904585D1 (de) 2003-01-30
NO995225D0 (no) 1999-10-26
DK1074558T3 (da) 2003-04-07
CA2295455C (en) 2008-03-25
HRP990341A2 (en) 2001-04-30
NO321154B1 (no) 2006-03-27
CA2295455A1 (en) 2001-02-02
SI1074558T1 (en) 2003-04-30

Similar Documents

Publication Publication Date Title
IL105421A0 (en) Taxol derivatives
IL133752A0 (en) Process for the preparation of mometasone furoate
EP1401433A4 (en) CONSTANTLY CONFORMING ANALOGUES AS AGENTS AGAINST DIABETES AND AGAINST OBESITY, AND ASSOCIATED METHOD
WO2002032898A3 (de) Neue anticholinergika, verfahren zu deren herstellung und deren verwendung als arzneimittel
HUP0201711A2 (en) Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as a medicament and pharmaceutical preparations containing the same
AU6093296A (en) Infectious dengue 2 virus pdk-53 as quadravalent vaccine
DK0717041T3 (da) Krystallinske paclitaxel-hydrater
ZA200201816B (en) A vaccine composition and method of using the same.
IL108681A0 (en) Influenza vaccine compositions
AU1951495A (en) Alphavirus rna as carrier for vaccines
HK1026146A1 (en) A universally applicable blood plasma
NZ295238A (en) Immunogenic compositions characterised by the carrier being a hydrophobic solvent in the absence of a hydrophilic phase
DE4493718T1 (de) Abbaubare Succinsäurederivatchelanten, Verwendungen und Zusammensetzungen davon
ZA992354B (en) A formulation of dihydroartemisinin for the control of wide spectrum of malaria and a process for preparing the same.
WO1997013776A3 (fr) Nouveaux derives amines de 2', 3' didesoxyglycosides d'epipodophyllotoxine, leur procede de preparation, leur utilisation comme medicament et leur utilisation destinee aux traitements anticancereux
AU7773900A (en) Novel c13-substituted estra-1,3,5(10)-triene-3-yl-sulfamates, a method for producing the same and pharmaceutical compositions containing these compounds
FI945414A (fi) Menetelmä N,N-disubstituoidun aminofenolin valmistamiseksi
SI0934780T1 (zh)
FR2686090B1 (fr) Composition a base de polysilane(s), non degradable par hydrosilylation.
HU9801086D0 (en) New benzofurane derivatives, pharmaceutical compositions containing them as active component and process for producing the active component
IT1294969B1 (it) Composizione immunogena per hiv